135 results on '"Van De Ven, Katinka"'
Search Results
2. Drugs and Public Health
3. Illicit Performance and Image Enhancing Drug Markets in the Netherlands and Belgium
4. The pharmaceuticalisation of ‘healthy’ ageing: Testosterone enhancement for longevity
5. Testing the boundaries: Self-medicated testosterone replacement and why it is practised
6. The impact of rurality on opioid-related harms: A systematic review of qualitative research
7. The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis.
8. ‘The Fittest on Earth’: Performance and Image Enhancing Drugs Use Within UK CrossFit Communities
9. The formation and development of illicit performance and image enhancing drug markets : exploring supply and demand, and control policies in Belgium and the Netherlands
10. Overview of “home” cultivation policies and the case for community-based cannabis supply
11. Illicit Performance and Image Enhancing Drug Markets in the Netherlands and Belgium
12. Performance and image enhancing drug (PIED) producers and suppliers: a retrospective content analysis of PIED-provider cases in Australia from 2010-2016
13. The Association Between the Nonmedical use of Anabolic–Androgenic Steroids and Interpersonal Violence: A Meta-Analysis
14. “More than just counting the plants”
15. The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview
16. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation
17. Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium
18. Australian police detainees who use anabolic-androgenic steroids (AAS) and their involvement in violent crimes compared to detainees using substances other than AAS
19. Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors
20. Human enhancement drugs and Armed Forces: an overview of some key ethical considerations of creating ‘Super-Soldiers’
21. ‘Blurred lines’: Anti-doping, national policies, and the performance and image enhancing drug (PIED) market in Belgium and The Netherlands
22. Substance use in elite and recreational sport
23. Substance use in elite and recreational sport
24. Illicit Performance and Image Enhancing Drug Markets
25. The symbiotic evolution of anti-doping and supply chains of doping substances: how criminal networks may benefit from anti-doping policy
26. Human enhancement drugs: Emerging issues and responses
27. Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research
28. The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids
29. Are market mechanisms associated with alcohol and other drug treatment outcomes?
30. Seeking legitimacy for broad understandings of substance use
31. Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
32. Human enhancement drugs and new(?) research directions
33. Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research
34. Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field
35. There’s a (drug policy) storm coming
36. The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked?
37. The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study
38. Is health or social welfare the right question? Response to commentaries
39. Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?
40. The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked?
41. Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field.
42. Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment.
43. Welcome message from the new Editor-in-Chief
44. Performance and image enhancing drug (PIED) producers and suppliers: a retrospective content analysis of PIED-provider cases in Australia from 2010-2016
45. Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia
46. The Internet and lifestyle drugs: an analysis of demographic characteristics, methods, and motives of online purchasers of illicit lifestyle drugs in the Netherlands
47. The Formation and Development of Illicit Performance and Image Enhancing Drug Markets: Exploring Supply and Demand, and Control Policies in Belgium and the Netherlands
48. ‘Counting your steps’: The use of wearable technology to promote employees’ health and wellbeing
49. Commentary: Steroid Madness- has the dark side of anabolic-androgenic steroids (AAS) been over-stated?
50. Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.